Lei Wu

Lei Wu

Auto-generated profile, based on publicly available information

Lei Wu

School of Biomedical Engineering, Sun Yat-sen University, Guangzhou, 510006, Guangdong, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2021 in Bioactive Materials
Verified
Journal Article
Open access
LWLei Wu
Lei Wu
WZWenhui Zhou
Wenhui Zhou
LLLihua Lin
Lihua Lin
ACAnhong Chen
Anhong Chen
JFJing Feng
Jing Feng
JYJun Yue
Jun Yue
Therapeutic oligonucleotides (TOs) represent one of the most promising drug candidates in the targeted cancer treatment due to their high specificity and capability of modulating cellular pathways that are not readily druggable. However, efficiently delivering of TOs to cancer cellular targets is still the biggest challenge in promoting their clinical translations. Emerging as a significant drug delivery vector, nanoparticles (NPs) can not only protect TOs from nuclease degradation and enhance their tumor accumulation, but also can improve the cell uptake efficiency of TOs as well as the following endosomal escape to increase the therapeutic index. Furthermore, targeted and on-demand drug release of TOs can also be approached to minimize the risk of toxicity towards normal tissues using stimuli-responsive NPs. In the past decades, remarkable progresses have been made on the TOs delivery based on various NPs with specific purposes. In this review, we will first give a brief introduction on the basis of TOs as well as the action mechanisms of several typical TOs, and then describe the obstacles that prevent the clinical translation of TOs, followed by a comprehensive overview of the recent progresses on TOs delivery based on several various types of nanocarriers containing lipid-based nanoparticles, polymeric nanoparticles, gold nanoparticles, porous nanoparticles, DNA/RNA nanoassembly, extracellular vesicles, and imaging-guided drug delivery nanoparticles.

1 March 2019 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
BXBin Xu
Bin Xu
LWLei Wu
Lei Wu
ZJZiying Jin
Ziying Jin
XCXiaowei Chen
Xiaowei Chen
CCCao Chen
Cao Chen
QSQiang Shu
Qiang Shu

3 January 2021 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
XLXia Liu
Xia Liu
ZRZhi Ruan
Zhi Ruan
XSXing-Cheng Shao
Xing-Cheng Shao
HFHong-Xuan Feng
Hong-Xuan Feng
LWLei Wu
Lei Wu
NZNaixia Zhang
Naixia Zhang